JQ, Any news on MITI? It has climbed from 5 to 7 in a month on no news. Luckily I got 1000 shares at 5.5 which I am holding for a long long time :-) Here is my list of candidates: 1. BiTE antibody/immunotherapy: MITI, CLDX 2. Generic/biosimilar/biobetter: PLX, MNTA 3. Ultrafast insulin: HALO, BIOD 4. Small molecule kinase inhibitor: ARRY, PCYC, EXEL 5. Antibody conjugate: IMGN, SGEN 5. Drug delivery/modification of existing drug: NKTR, HALO 6. Established small/mid cap: BMRN, ONXX